Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.

about

Inducible pluripotent stem cell-derived mesenchymal stem cell therapy effectively protected kidney from acute ischemia-reperfusion injury Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models

P2860

Q58733966-FB315177-5718-45DF-9A68-27680DD0B28B Q58762401-C9A71618-1E2B-4729-A442-8FB258AB959C

P2860

Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.

Item

http://www.wikidata.org/entity/Q48323464

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Modeling Parkinson's disease w ...... rboring α-synuclein mutations.

@en

Modeling Parkinson's disease w ...... rboring α-synuclein mutations.

@nl

type

Item

label

Modeling Parkinson's disease w ...... rboring α-synuclein mutations.

@en

Modeling Parkinson's disease w ...... rboring α-synuclein mutations.

@nl

prefLabel

Modeling Parkinson's disease w ...... rboring α-synuclein mutations.

@en

Modeling Parkinson's disease w ...... rboring α-synuclein mutations.

@nl

P1476

Modeling Parkinson's disease w ...... rboring α-synuclein mutations.

@en

P2093

Fella Hammachi

http://www.w3.org/2001/XMLSchema#string

Karamjit Singh Dolt

http://www.w3.org/2001/XMLSchema#string

P2860

Kinase activity of mutant LRRK2 mediates neuronal toxicity

Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications

Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

alpha-Synuclein locus triplication causes Parkinson's disease

Alpha-synuclein in Lewy bodies

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

P304

545-551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPA.12526

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tilo Kunath

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28585381

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

Synuclein

Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.

about

P2860

P2860

Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921